What Researchers Did
Researchers conducted a systematic review and meta-analysis of 13 controlled trials to evaluate the efficacy and safety of hyperbaric oxygenation therapy as an adjunctive treatment for chronic diabetic foot ulcers.
What They Found
Adjunctive hyperbaric oxygenation therapy significantly increased the proportion of healed diabetic ulcers (relative risk, 2.33) and reduced the risk of major amputations by 71% (relative risk, 0.29) compared to treatment without HBO. Adverse events associated with HBO were rare, reversible, and not more frequent than in control groups.
What This Means for Canadian Patients
Canadian patients with chronic diabetic foot ulcers may experience improved wound healing and a reduced risk of major amputations if hyperbaric oxygenation therapy is used as an additional treatment. This could potentially lead to better long-term outcomes and preserve limb function for those affected by this serious complication of diabetes.
Canadian Relevance
This study did not include any Canadian participants or researchers, so there is no direct Canadian connection.
Study Limitations
The study's limitations may include potential heterogeneity among the included trials and the quality of the primary studies.